JP2009523764A - 抗菌活性を有するジカルボニル化合物 - Google Patents

抗菌活性を有するジカルボニル化合物 Download PDF

Info

Publication number
JP2009523764A
JP2009523764A JP2008550756A JP2008550756A JP2009523764A JP 2009523764 A JP2009523764 A JP 2009523764A JP 2008550756 A JP2008550756 A JP 2008550756A JP 2008550756 A JP2008550756 A JP 2008550756A JP 2009523764 A JP2009523764 A JP 2009523764A
Authority
JP
Japan
Prior art keywords
nre
alkyl
nrh
alkynyl
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008550756A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009523764A5 (https=
Inventor
ホセ・イダルゴ・ロドリゲス
フアン・ロレンソ・カテナ・ルイス
イサベル・マシプ・マシプ
マリア・デル・カルメン・セラ・コマス
オスカル・レイ・プイグロス
カルメン・ラグナス・アルナル
カロリナ・サルセド・ロカ
ドロルス・バルサ・ロペス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Salvat SA
Original Assignee
Laboratorios Salvat SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Salvat SA filed Critical Laboratorios Salvat SA
Publication of JP2009523764A publication Critical patent/JP2009523764A/ja
Publication of JP2009523764A5 publication Critical patent/JP2009523764A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/14—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
JP2008550756A 2006-01-19 2007-01-18 抗菌活性を有するジカルボニル化合物 Withdrawn JP2009523764A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200600158 2006-01-19
PCT/EP2007/050489 WO2007082910A1 (en) 2006-01-19 2007-01-18 Dicarbonylic compounds with antibacterial activity

Publications (2)

Publication Number Publication Date
JP2009523764A true JP2009523764A (ja) 2009-06-25
JP2009523764A5 JP2009523764A5 (https=) 2010-03-04

Family

ID=37781676

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008550756A Withdrawn JP2009523764A (ja) 2006-01-19 2007-01-18 抗菌活性を有するジカルボニル化合物

Country Status (9)

Country Link
US (1) US20100075984A1 (https=)
EP (1) EP1976837A1 (https=)
JP (1) JP2009523764A (https=)
KR (1) KR20080108977A (https=)
CN (1) CN101405277A (https=)
AU (1) AU2007206889A1 (https=)
BR (1) BRPI0706938A2 (https=)
CA (1) CA2637052A1 (https=)
WO (1) WO2007082910A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5291292B2 (ja) * 2007-02-01 2013-09-18 協同油脂株式会社 金属加工用油剤及び金属加工方法
EP2367820B1 (en) * 2008-11-20 2016-09-21 Panacea Biotec Limited Novel antimicrobial agents
BR112012000657A2 (pt) 2009-06-26 2016-11-16 Panacea Biotec Ltd novos azabicilohexanos
WO2011002067A1 (ja) * 2009-07-02 2011-01-06 武田薬品工業株式会社 複素環化合物およびその用途
CN109503569B (zh) * 2019-01-03 2021-01-15 山东大学 噻唑类衍生物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2180456B1 (es) * 2001-07-20 2004-05-01 Laboratorios S.A.L.V.A.T., S.A. Isoxazoles sustituidos y su utilizacion como antibioticos.
MXPA05001199A (es) * 2002-07-29 2005-05-16 Ranbaxy Lab Ltd Derivados de oxazolidinona como antimicrobianos.
WO2005082892A2 (en) * 2004-02-17 2005-09-09 Dr. Reddy's Laboratories Ltd. Triazole compounds as antibacterial agents and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
US20100075984A1 (en) 2010-03-25
CN101405277A (zh) 2009-04-08
WO2007082910A1 (en) 2007-07-26
EP1976837A1 (en) 2008-10-08
CA2637052A1 (en) 2007-07-26
BRPI0706938A2 (pt) 2011-04-12
KR20080108977A (ko) 2008-12-16
AU2007206889A1 (en) 2007-07-26

Similar Documents

Publication Publication Date Title
RU2278117C2 (ru) Антибактериальные гетеробициклические замещенные фенилоксазолидиноны
JP5153329B2 (ja) （ｒ／ｓ）リファマイシン誘導体、その調製、および医薬組成物
JP2005520815A (ja) 二環式複素環式の置換されたフェニルオキサゾリジノン抗細菌剤、関連組成物および方法
EP1246810B1 (en) Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidinones as antibacterials
EP4286001A2 (en) Benzoylglycine derivatives and methods of making and using same
JP2009523764A (ja) 抗菌活性を有するジカルボニル化合物
US20030176422A1 (en) Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
RU2417223C2 (ru) Оксазолидиноновые производные, способ их получения (варианты) и фармацевтическая композиция на их основе
JP5662940B2 (ja) 新規な抗微生物薬
CN104981469A (zh) 抗微生物剂
FR2928150A1 (fr) Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens
AU2005266318A1 (en) Oxazolidinone compounds and compositions and methods related thereto
CN117730079A (zh) 作为rsv感染症的治疗及/或预防用医药的经杂环烷基取代的聚杂唑衍生物
CN116283925A (zh) 一种用于治疗细菌感染的亚胺吩嗪衍生偶联分子及其应用
EP2072514A1 (en) 1(2)H-tetrazol-5-yl-phenyl-oxazolidinones as antibacterial agents
HK40104425A (en) Benzoylglycine derivatives and methods of making and using same
CN121270632A (zh) 一种大环内酯的喹诺酮衍生物及其制备方法和应用
HK1116482B (en) Oxazolidinone derivatives and use thereof as antibiotics

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100115

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100115

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20110525